We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Hydrophobic Proteins May Become Biomarkers for Colorectal Cancer

By LabMedica International staff writers
Posted on 16 Sep 2010
New findings using two-dimensional gel electrophoresis (2D-PAGE) technology may be used to design drug targeted therapy for the treatment of colorectal cancer.

In the study, hydrophobic proteins extracted from colorectal cancer tissues were separated using 2D-PAGE according to their isoelectric point and molecular weight, subsequently, the protein profiles between cancerous and normal tissues were compared. More...
Using this approach, researchers identified a few differentially expressed proteins that were upregulated in cancerous tissues. The expression of such proteins was shown to be significantly related to stage and grade of the cancer and also to gender of the patients.

Colorectal cancer, cancer of the colon and rectum, is a common cause of mortality worldwide. Statistical data demonstrated that the number of deaths caused by colorectal cancer is increasing in both men and women. Understanding the differential expression of proteins in colorectal cancer and normal tissues will lead to a better determination of the development of the disease. Furthermore, these proteins may serve as biomarkers for treatment or detection of the disease. Hydrophobic proteins play a key role in various cellular processes, by virtue of their cellular location, and may serve as a target for drug-targeted therapy.

The study was led by associate professor Dr. Gam Lay Harn from the Universiti Sains Malaysia (Pulau Pinang, Malaysia) and was published on June 14, 2010, in the World Journal of Gastroenterology. Although the extraction of hydrophobic proteins from tissues poses certain challenges, a combination of protein reagents can be used successfully to extract this group of proteins. Followed by 2D-gel electrophoresis separation and mass spectrometry analysis, the identity of these proteins can be validated.

The results obtained in this study revealed the differentially expressed proteins between colorectal cancerous and normal tissues. These proteins may indicate the progression of colorectal carcinogenesis. Furthermore, they can potentially be used to design drug-targeted therapy for the treatment of colorectal cancer.

Related Links:

Universiti Sains Malaysia




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Pan-Cancer Panel
TruSight Oncology 500
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.